Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

fengabine

Known as: 2-(N-butyl-o-chlorobenzimidoyl)-4-chlorophenyl 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryGamma-aminobutyric acid (GABA) and GABA agonists exhibited biphasic response on forced swimming-induced despair behavior… Expand
  • table 2
  • table 1
  • figure 1
  • table 3
  • table 4
1993
1993
1. The effects of fengabine were compared with those of amitriptyline in healthy elderly volunteers. Doses were administered… Expand
1991
1991
A double‐blind controlled trial of Fengabine, a GABA agonist, against placebo was carried out in outpatient major depressives… Expand
1990
1990
The results of a double‐blind clinical trial of fengabine vs clomipramine in depressed outpatients are reported. Fengabine, a new… Expand
1990
1990
The possible involvement of gamma-aminobutyric acid/benzodiazepine (GABA-BZ) receptor modulation in scopolamine-induced short… Expand
1989
1989
A sensitive capillary gas chromatographic method was developed for the determination of fengabine (a GABAergic antidepressant… Expand
1988
1988
The effect of fengabine (a novel benzylidene derivative) on neuropsychopharmacological parameters was investigated in mice. On… Expand
1987
1987
The effects of fengabine (a novel benzylidene derivative possessing clinically demonstrated antidepressant action) on… Expand
1987
1987
Fengabine (SL 79.229) is a novel benzylidene derivative with clinically proven antidepressant action. Fengabine is active in… Expand
Review
1987
Review
1987
Recently sufficient evidence has accumulated to propose that a central GABAergic dysfunction may be primarily related to the… Expand